Notice Information
Notice Title
Call for information/EOI for neutralising antibodies.
Notice Description
DHSC invites suppliers to submit an EOI on neutralising antibodies and binding site, clinical trials on efficacy, safety for preventing or treating COVID-19 infection, dose&frequency, formats/routes for administering to patients, monitoring adverse affects, efficacy against SARSCoV- 2 variants, supply availability for 2021- 2022 and future years and plans for regulatory approval in the UK, if not yet approved. **Updated information on 9th December 2021** The Therapeutics Taskforce is responsible for the end-to-end provision of treatments for COVID-19 in the UK, from the initial identification of potential therapeutics, to trialing treatments as part of an advanced programme of clinical trials, and their eventual deployment at scale to the patient population. These safe and effective treatments are vital for lessening the severity and impact of COVID-19 in individuals and communities. The Taskforce is seeking to gather information in respect of neutralising antibodies that can be deployed in a hospital or community setting. Therapeutics suppliers must provide evidence of their therapies' potential efficacy and progress in trials, monitoring and safety. The market engagement will take the form of a webinar held on Thursday 16th December 2021. The webinar will take interested suppliers through the requirement outlined in this Prior Information Notice and will provide an opportunity for suppliers to ask questions. To sign up to join the webinar please visit: https://www.eventbrite.co.uk/e/prior-information-notice-antiviral-drug-supply-for-covid-19-webinar-tickets-225298643307 We are inviting suppliers to register their interest in the PIN by downloading a questionnaire via the Atamis platform, and sending a completed version to http://health.atamis.co.uk by 13:00 on 23rd December 2021. Responses to this questionnaire will be kept in confidence and will inform the Taskforce's market research. Suppliers are not required to fill out a questionnaire before attending the webinar. Any information shared in the webinar will be shared with all suppliers via the Atamis platform after the market engagement period associated with this PIN closes on Thursday 23rd December 2021.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-b5fd17-c665099e-1e27-40a1-933d-a4a61fc01d2c
- Publication Source
- Contracts Finder
- Latest Notice
- https://www.contractsfinder.service.gov.uk/Notice/b16a9c81-97ef-4281-8a4f-5486929f4621
- Current Stage
- Planning
- All Stages
- Planning
Procurement Classification
- Notice Type
- Market Engagement Notice
- Procurement Type
- Standard
- Procurement Category
- Goods
- Procurement Method
- Not Specified
- Procurement Method Details
- Not specified
- Tender Suitability
- Not specified
- Awardee Scale
- Not specified
Common Procurement Vocabulary (CPV)
- CPV Divisions
33 - Medical equipments, pharmaceuticals and personal care products
-
- CPV Codes
33600000 - Pharmaceutical products
Notice Value(s)
- Tender Value
- £1
- Lots Value
- Not specified
- Awards Value
- Not specified
- Contracts Value
- Not specified
Notice Dates
- Publication Date
- 9 Dec 20214 years ago
- Submission Deadline
- Not specified
- Future Notice Date
- 31 Mar 2022Expired
- Award Date
- Not specified
- Contract Period
- Not specified - Not specified
- Recurrence
- Not specified
Notice Status
- Tender Status
- Planning
- Lots Status
- Not Specified
- Awards Status
- Not Specified
- Contracts Status
- Not Specified
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- DEPARTMENT OF HEALTH AND SOCIAL CARE
- Contact Name
- Available with D3 Tenders Premium →
- Contact Email
- Available with D3 Tenders Premium →
- Contact Phone
- Available with D3 Tenders Premium →
Buyer Location
- Locality
- LONDON
- Postcode
- SW1H 0EU
- Post Town
- South West London
- Country
- England
-
- Major Region (ITL 1)
- TLI London
- Basic Region (ITL 2)
- TLI3 Inner London - West
- Small Region (ITL 3)
- TLI35 Westminster and City of London
- Delivery Location
- Not specified
-
- Local Authority
- Westminster
- Electoral Ward
- St James's
- Westminster Constituency
- Cities of London and Westminster
Further Information
Notice Documents
-
https://www.contractsfinder.service.gov.uk/Notice/b16a9c81-97ef-4281-8a4f-5486929f4621
9th December 2021 - Early engagement notice on Contracts Finder -
https://www.contractsfinder.service.gov.uk/Notice/fe4c8eb5-f04a-4d6f-8f3c-b74896334c55
5th October 2021 - Early engagement notice on Contracts Finder
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-b5fd17-c665099e-1e27-40a1-933d-a4a61fc01d2c-2021-12-09T18:15:47Z",
"date": "2021-12-09T18:15:47Z",
"ocid": "ocds-b5fd17-c665099e-1e27-40a1-933d-a4a61fc01d2c",
"language": "en",
"initiationType": "tender",
"title": "Call for information/EOI for neutralising antibodies.",
"planning": {
"milestones": [
{
"id": "1",
"title": "Engagement end date",
"type": "engagement",
"dueDate": "2022-03-31T23:59:59+01:00"
}
],
"documents": [
{
"id": "1",
"documentType": "marketEngagementNotice",
"description": "Early engagement notice on Contracts Finder",
"url": "https://www.contractsfinder.service.gov.uk/Notice/fe4c8eb5-f04a-4d6f-8f3c-b74896334c55",
"datePublished": "2021-10-05T16:40:17+01:00",
"format": "text/html",
"language": "en"
},
{
"id": "2",
"documentType": "marketEngagementNotice",
"description": "Early engagement notice on Contracts Finder",
"url": "https://www.contractsfinder.service.gov.uk/Notice/b16a9c81-97ef-4281-8a4f-5486929f4621",
"datePublished": "2021-10-05T16:40:17+01:00",
"dateModified": "2021-12-09T18:15:47Z",
"format": "text/html",
"language": "en"
}
]
},
"tender": {
"id": "CF-0367000D0O000000rwimUAA2",
"title": "Call for information/EOI for neutralising antibodies.",
"description": "DHSC invites suppliers to submit an EOI on neutralising antibodies and binding site, clinical trials on efficacy, safety for preventing or treating COVID-19 infection, dose&frequency, formats/routes for administering to patients, monitoring adverse affects, efficacy against SARSCoV- 2 variants, supply availability for 2021- 2022 and future years and plans for regulatory approval in the UK, if not yet approved. **Updated information on 9th December 2021** The Therapeutics Taskforce is responsible for the end-to-end provision of treatments for COVID-19 in the UK, from the initial identification of potential therapeutics, to trialing treatments as part of an advanced programme of clinical trials, and their eventual deployment at scale to the patient population. These safe and effective treatments are vital for lessening the severity and impact of COVID-19 in individuals and communities. The Taskforce is seeking to gather information in respect of neutralising antibodies that can be deployed in a hospital or community setting. Therapeutics suppliers must provide evidence of their therapies' potential efficacy and progress in trials, monitoring and safety. The market engagement will take the form of a webinar held on Thursday 16th December 2021. The webinar will take interested suppliers through the requirement outlined in this Prior Information Notice and will provide an opportunity for suppliers to ask questions. To sign up to join the webinar please visit: https://www.eventbrite.co.uk/e/prior-information-notice-antiviral-drug-supply-for-covid-19-webinar-tickets-225298643307 We are inviting suppliers to register their interest in the PIN by downloading a questionnaire via the Atamis platform, and sending a completed version to http://health.atamis.co.uk by 13:00 on 23rd December 2021. Responses to this questionnaire will be kept in confidence and will inform the Taskforce's market research. Suppliers are not required to fill out a questionnaire before attending the webinar. Any information shared in the webinar will be shared with all suppliers via the Atamis platform after the market engagement period associated with this PIN closes on Thursday 23rd December 2021.",
"status": "planning",
"classification": {
"scheme": "CPV",
"id": "33600000",
"description": "Pharmaceutical products"
},
"items": [
{
"id": "1",
"deliveryAddresses": [
{
"postalCode": "SW1H 0EU"
},
{
"countryName": "British Oversea Territories"
},
{
"countryName": "Channel Islands"
},
{
"countryName": "Europe"
},
{
"countryName": "Isle of Man"
},
{
"countryName": "Rest of the World"
},
{
"countryName": "United Kingdom"
},
{
"postalCode": "SW1H 0EU"
},
{
"countryName": "British Oversea Territories"
},
{
"countryName": "Channel Islands"
},
{
"countryName": "Europe"
},
{
"countryName": "Isle of Man"
},
{
"countryName": "Rest of the World"
},
{
"countryName": "United Kingdom"
}
]
}
],
"value": {
"amount": 1,
"currency": "GBP"
},
"suitability": {
"sme": false,
"vcse": false
},
"mainProcurementCategory": "goods"
},
"parties": [
{
"id": "GB-CFS-223191",
"name": "Department of Health and Social Care",
"identifier": {
"legalName": "Department of Health and Social Care"
},
"address": {
"streetAddress": "VICTORIA STREET",
"locality": "LONDON",
"postalCode": "SW1H 0EU",
"countryName": "GB"
},
"contactPoint": {
"name": "Amjad Kazmi",
"email": "amjad.kazmi@dhsc.gov.uk"
},
"roles": [
"buyer"
]
},
{
"id": "GB-CFS-191895",
"name": "Department of Health and Social Care",
"identifier": {
"legalName": "Department of Health and Social Care"
},
"address": {
"streetAddress": "39 VICTORIA STREET",
"locality": "LONDON",
"postalCode": "SW1H 0EU",
"countryName": "GB"
},
"contactPoint": {
"name": "Amjad Kazmi",
"email": "amjad.kazmi@dhsc.gov.uk"
},
"roles": [
"buyer"
]
}
],
"buyer": {
"id": "GB-CFS-191895",
"name": "Department of Health and Social Care"
}
}